Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 15,604 | 6,397 | 9,590 | 6,199 | 426 |
| Gross Profit | 15,604 | 6,397 | 9,590 | 6,199 | 426 |
| Operating Expenses | 38,333 | 26,258 | 28,690 | 14,284 | 5,485 |
| Operating Income | -22,729 | -19,861 | -19,100 | -8,085 | -5,059 |
| Interest Expense | 871 | 690 | 0 | 1,548 | 43 |
| Other Income | 1,347 | 2,004 | 2,740 | 3,096 | 262 |
| Pre-tax Income | -22,253 | -18,547 | -16,360 | -6,537 | -4,840 |
| Net Income Continuous | -22,253 | -18,547 | -16,369 | -6,537 | -4,839 |
| Net Income | $-22,253 | $-18,547 | $-16,360 | $-6,537 | $-4,840 |
| EPS Basic Total Ops | -1.65 | -1.43 | -690,733.40 | -342,649.50 | -282,819.10 |
| EPS Basic Continuous Ops | -1.65 | -1.43 | -691,113.30 | -342,649.50 | -282,760.70 |
| EPS Diluted Total Ops | -1.65 | -1.43 | -690,733.40 | -342,649.50 | -282,819.10 |
| EPS Diluted Continuous Ops | -1.65 | -1.43 | -691,113.30 | -342,649.50 | -282,760.70 |
| EBITDA(a) | $-19,605 | $-16,896 | $-17,090 | $-8,085 | $-4,615 |